Vanda Pharmaceuticals (VNDA) Tops Q4 EPS by 4c
Tweet
Share
E-mail
Get Alerts VNDA Hot Sheet
Price: $6.01 +3.62%
EPS Growth %: -30.4%
Financial Fact:
Product sales: 38.48M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -30.4%
Financial Fact:
Product sales: 38.48M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q4 EPS of $0.12, $0.04 better than the analyst estimate of $0.08. Revenue for the quarter came in at $64.5 million versus the consensus estimate of $67.6 million.
For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group
- Ennis (EBF) Reports In-Line Q1 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
